Gerresheimer stock holds at EUR 26.50 as Q1 update and AGM set the tone
Published on 08/31/2026 at 09:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Gerresheimer AG (ISIN DE000A0LD6E6) stock was last quoted at EUR 26.50 on August 28, 2026, giving investors a stable reference point ahead of the company’s virtual annual general meeting on August 31, 2026. Per recent reporting, preliminary first-quarter 2026 figures showed EUR 524 million in revenue and EUR 66 million in adjusted EBITDA, together with a marked recovery in free cash flow compared with the prior year.
Q1 2026 figures highlight improving cash flow
According to a same-day market overview, Gerresheimer’s preliminary first-quarter 2026 revenue came in at EUR 524 million, setting the latest top-line marker for the packaging specialist’s new financial year. The company also reported adjusted EBITDA of EUR 66 million in the same period, underlining earnings power in a market that continues to demand high-quality pharmaceutical and healthcare containers.
The cash-flow picture stood out: free cash flow in the first quarter of 2026 was reported at minus EUR 32 million, a significant improvement compared with minus EUR 141 million in the first quarter of 2025. This means the free cash flow deficit narrowed by EUR 109 million year over year, a change that investors often interpret as an early sign that operating performance and capital discipline are moving in the right direction even before the full-year numbers are available.
AGM on August 31, 2026 adds a key checkpoint
Gerresheimer has scheduled its virtual annual general meeting for August 31, 2026, giving shareholders a clear date to hear more about the company’s strategy and outlook for the rest of the year. The AGM comes five days after the publication of the preliminary first-quarter 2026 figures, creating a compressed information window in which management can explain the drivers behind revenue, EBITDA, and cash-flow developments and set expectations for subsequent quarters.
Market data from late August 2026 showed the shares trading at EUR 26.50 on Tradegate at 10:25 p.m. ET on August 28, 2026, with a modest gain of 0.15 percent on the day. At that level, Gerresheimer stock is positioned within the healthcare and pharmaceutical packaging segment of the SDAX, giving it exposure to both defensive healthcare demand and the broader German small-cap index performance. For investors, the combination of a stable price level ahead of the AGM and a clear improvement in free cash flow compared with the prior year frames the upcoming shareholder meeting as an important moment for confirming the sustainability of the trend.
Primary packaging for pharmaceuticals as a core business
Gerresheimer’s core business revolves around primary packaging solutions for the pharmaceutical industry, including glass and plastic containers, vials, and syringes designed to meet strict regulatory requirements. These products underpin long-term relationships with drug manufacturers, which rely on consistent quality and reliable supply for medicines ranging from everyday generics to complex biologics. Because demand for such packaging tends to track underlying volumes in pharmaceuticals rather than short-term economic cycles, the segment often offers a degree of resilience, and any operational improvements seen in metrics like EBITDA and cash flow feed directly into the company’s capacity to invest in specialized production lines and innovation in packaging formats.
Gerresheimer stock and current trading level
Gerresheimer stock most recently traded at EUR 26.50 on Tradegate as of August 28, 2026, 10:25 p.m. ET, giving a clear price marker for the shares going into the August 31, 2026 AGM. With the first-quarter 2026 revenue at EUR 524 million and adjusted EBITDA at EUR 66 million, alongside the EUR 109 million year-over-year improvement in free cash flow, the current trading level reflects a balance between the company’s operational progress and the broader valuation framework for SDAX-listed healthcare names.
Fact box
Company: Gerresheimer AG
ISIN: DE000A0LD6E6
Ticker: GXI
Exchange: Tradegate
Price (as of August 28, 2026, 10:25 p.m. ET): EUR 26.50
Sector / Industry: Healthcare / Pharmaceutical packaging
Index membership: SDAX
